Colorectal Cancer Update
A Continuing Medical Education Audio Series
STATEMENT OF NEED / TARGET AUDIENCE
Colorectal cancer is among the most common cancers in the United States, and the arena of colorectal cancer treatment
continues to evolve. Published results from ongoing clinical trials lead to the emergence of new therapeutic agents and
regimens and changes in indications, doses and schedules for existing treatments. In order to offer optimal patient care
— including the option of clinical trial participation — the practicing medical oncologist must be well informed of these
advances.
To bridge the gap between research and patient care, Colorectal Cancer Update utilizes discussions with leading oncology
investigators. By providing access to the latest research developments and expert perspectives, this CME activity assists
medical oncologists in the formulation of up-to-date clinical management strategies.
GLOBAL LEARNING OBJECTIVES
- Critically evaluate the clinical implications of emerging clinical trial data in colorectal cancer treatment, and incorporate
these data into management strategies in the local and advanced disease settings.
- Counsel appropriate patients about the availability of ongoing clinical trials.
- Evaluate the emerging research data on various adjuvant chemotherapy approaches, including the use of oxaliplatin-containing
regimens and the use of capecitabine or intravenous 5-FU, and explain the absolute risks and benefits of
these regimens to patients.
- Evaluate emerging research data on various neoadjuvant radiation therapy/chemotherapy approaches to rectal cancer
and explain the absolute risks and benefits of these regimens to patients.
- Integrate emerging data on biologic therapies into management strategies for patients with advanced colorectal
cancer.
PURPOSE OF THIS ISSUE OF COLORECTAL CANCER UPDATE
The purpose of this special edition of Colorectal Cancer Update is to support these global objectives by offering the
perspectives of Drs Berlin, Ellis, Fuchs, Goldberg, Grothey, Haller, Hochster, Hurwitz, Meropol, Tepper, Wolff and Wolmark
on the integration of emerging clinical research data into the management of colorectal cancer.
ACCREDITATION STATEMENT
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing
medical education for physicians.
CREDIT DESIGNATION STATEMENT
Research To Practice designates this educational activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
HOW TO USE THIS CME ACTIVITY
This CME activity contains both audio and print components. To receive credit, the participant should listen to the CDs, review the Internet content and complete the Post-test and Evaluation Form located at www.ColorectalCancerUpdate.com/CME. www.ColorectalCancerUpdate.com contains edited comments, clinical trial schemas, graphics and references that supplement the audio program, as well as links to relevant full-text articles, abstracts, trial information and other web resources.
This program is supported by education grants from AstraZeneca Pharmaceuticals LP, Genentech
BioOncology and Sanofi-Aventis.
